Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

A reptile hunter sprang into action last week to remove a 16-foot python that was slithering around a dumpster at a Los Angeles apartment building. Dramatic video shows 24-year-old Joseph Hart — ...

LOS ANGELES (KABC) -- What would you do if you found a 20-foot python in your apartment complex's dumpster? Well, that's exactly what happened Tuesday in Los Angeles. Joseph Hart - who's known as the ...

During the last three months, 4 analysts shared their evaluations of Recursion Pharmaceuticals (NASDAQ:RXRX), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of ...

Friday night, June 6, a North Texas neighborhood in Garland was on edge as a 15-foot reticulated python escaped from his owner and was on the loose slithering through the streets. CBS Texas reports ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

Recursion said it will end development for four of its 11 pipeline programs—one of which the company will consider outlicensing to a partner instead—and pause a fifth program, in a pruning designed to ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...

TIOBE Programming Index News December 2024: Python Maintains Its Lead Your email has been sent The top three points toward a winner for the year’s best, while the bottom three switch spots. Python is ...